Journal
Scientific Reports
Publication Date
8-9-2025
Volume
15
Issue
1
First Page
29168
Document Type
Open Access Publication
DOI
10.1038/s41598-025-07315-9
Rights and Permissions
Wang, Y., Hu, T., Chang, CH. et al. Assessing buprenorphine treatment utilization and SAMHSA DATA waiver provider distribution in 2021: a real-world analysis in California. Sci Rep 15, 29168 (2025). https://doi.org/10.1038/s41598-025-07315-9 This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.
Recommended Citation
Wang, Yun; Hu, Tao; Chang, Chih-Hung; Heshmatipour, Matthew; Guo, Jeff Jianfei; Roosan, Moom R; and Miotto, Karen A, "Assessing buprenorphine treatment utilization and SAMHSA DATA waiver provider distribution in 2021: A real-world analysis in California." Scientific Reports. 15, 1. 29168 (2025).
https://digitalcommons.wustl.edu/oa_4/5478
Department
ICTS (Institute of Clinical and Translational Sciences)
Additional Links
Supplemental material is available for this article at publisher site.
